Suchergebnisse - "Bertaglia, Valentina"

PubPharm (44)

1

Malignant Pleural Mesothelioma : Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors

enthalten in: Targeted oncology | 2024

von Martella, S. | Aiello, M. | Bertaglia, V. | +10

2

Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening : A Literature Review

enthalten in: Cancers | 2023

von Garbo, E. | Del Rio, B. | Ferrari, G. | +7

3

The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer

enthalten in: Cancers | 2023

von Denaro, N. | Romanò, R. | Alfieri, S. | +8

4

Infections in lung cancer patients undergoing immunotherapy and targeted therapy : An overview on the current scenario

enthalten in: Critical reviews in oncology/hematology | 2023

von Bertaglia, V. | Morelli, A. | Solinas, C. | +6

5

Adjuvant chemotherapy for resected triple negative breast cancer patients : A network meta-analysis

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Petrelli, F. | Bertaglia, V. | Parati, M. | +7

6

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience

enthalten in: Biomedicines | 2023

von Persano, I. | Cani, M. | Del Rio, B. | +21

7

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer

enthalten in: Cells | 2022

von Mariniello, A. | Tabbò, F. | Indellicati, D. | +19

8

Assessment of clinical studies evaluating combinations of immune checkpoint inhibitors with locoregional treatments in solid tumors

enthalten in: Cytokine & growth factor reviews | 2022

von Bertaglia, V. | Petrelli, F. | Porcu, M. | +5

9

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer : a literature review

enthalten in: Translational lung cancer research | 2022

von Passiglia, F. | Bironzo, P. | Bertaglia, V. | +3

10

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma

enthalten in: Critical reviews in oncology/hematology | 2022

von Tagliamento, M. | Bironzo, P. | Curcio, H. | +18

1
2
3
4
5
Nächster »
[5]